Clinical Trials on Vascular

Total 50540 results

Heidelberg University

Unknown

Intravitreal Triamcinolone Acetonide for Diabetic Macular Edema

Diabetic Retinopathy | Diabetic Macular Edema

Germany
Aleris Helse
Novartis

Completed

A Randomized Study Comparing Ranibizumab to Sham in Patients With Macular Edema Secondary to CRVO

Central Retinal Vein Occlusion | Macular Edema

Norway
Hoffmann-La Roche
Chugai Pharmaceutical

Completed

A Study to Evaluate the Efficacy and Safety of Faricimab in Participants With Macular Edema Secondary to Branch Retinal Vein Occlusion (BALATON)

Macular Edema | Branch Retinal Vein Occlusion

United States, Korea, Republic of, Brazil, Japan, United Kingdom, China, Argentina, Australia, France, Germany, Hungary, Italy, Poland, Spain, Singapore, Austria, Czechia, Hong Kong, Israel, Portugal, Russian Federation, Taiwan
4D Molecular Therapeutics

Recruiting

4D-150 in Patients With Diabetic Macular Edema

Diabetic Retinopathy | Diabetic Macular Edema

United States, Puerto Rico
Kim's Eye Hospital

Completed

Outcomes of Tolerating Subretinal Fluid in Type 1 MNV and PCV

Age-Related Macular Degeneration | Choroidal Neovascularization | Polypoidal Choroidal Vasculopathy

Korea, Republic of
Oxurion

Completed

A Study to Evaluate THR-149 Treatment for Diabetic Macular Oedema (KALAHARI)

Diabetes Mellitus | Diabetic Retinopathy | Diabetic Macular Edema

United States, France, United Kingdom, Spain, Germany, Italy, Slovakia, Czechia
Vital Art and Science Incorporated
National Eye Institute (NEI); University of Texas Southwestern Medical Center; Retina Foundation of the Southwest and other collaborators

Completed

Diabetic Retinopathy And the Myvisiontrack® (DRAMA) Study (DRAMA)

Diabetic Retinopathy | Diabetic Macular Edema

United States
Rafic Hariri University Hospital

Unknown

Ziv-aflibercept in Eyes With Retinal Diseases and Poor Vision-phase I (ZIV)

Central Retinal Vein Occlusion | Age Related Macular Degeneration

Lebanon
Fovea Pharmaceuticals SA

Completed

Safety and Efficacy Study of Topical Administration of FOV2304 (High Dose or Low Dose) for the Treatment of Center-involving Clinically Significant Macular Edema Associated With Diabetic Retinopathy

Diabetic Macular Edema

United States, Australia, Belgium, Czech Republic, France, Germany, Israel, Italy, Poland, Spain
Asociación para Evitar la Ceguera en México

Completed

Unilateral Bevacizumab for Bilateral Diabetic Macular Edema

Diabetic Retinopathy | Diabetic Macular Edema

Mexico
The New York Eye & Ear Infirmary

Unknown

Age-related Macular Degeneration (AMD) and Cardiovascular Disease

Cardiovascular Diseases | Coronary Artery Disease | Age-related Macular Degeneration

United States
Helse Stavanger HF

Terminated

Combined Vitrectomy and Triamcinolone in Macular Edema Secondary to Branch Retinal Vein Occlusion (BRVO)

Macular Edema | Branch Retinal Vein Occlusion

Norway
Asociación para Evitar la Ceguera en México

Unknown

Treatment of Bevacizumab and Triamcinolone in Treatment or Macular Edema Secondary to CRVO (MECROV)

Central Retinal Vein Occlusion | Macular Edema

Mexico
Outlook Therapeutics, Inc.

Active, not recruiting

A 3-month Study to Compare the Safety of ONS-5010 in Vials Versus Pre-filled Syringe in Subjects With Visual Impairment Due to Retinal Disorders (NORSE SEVEN)

Age-Related Macular Degeneration | Diabetic Macular Edema | Wet Macular Degeneration | Neovascular Age-related Macular Degeneration | BRVO - Branch Retinal Vein Occlusion

United States
Duke University
Optovue

Terminated

SD-OCT Angiography

Diabetic Retinopathy | Age-related Macular Degeneration | Diabetic Macular Edema | Retinal Vein Occlusion | Neovascular Age-related Macular Degeneration

United States
Outlook Therapeutics, Inc.

Completed

A 3-month Study to Assess the Safety of ONS-5010 in Subjects With Visual Impairment Due to Retinal Disorders

Age-related Macular Degeneration | Diabetic Macular Edema | Wet Macular Degeneration | Neovascular Age-related Macular Degeneration | BRVO - Branch Retinal Vein Occlusion

United States
South Warwickshire NHS Foundation Trust
Aston University

Unknown

Polarization Perception in Health and Disease. Testing a New Sight Test (TaNSiT)

Diabetic Retinopathy | Cataract | Age Related Macular Degeneration | Macular Disease | Pseudophakia | Retinal Disease

United Kingdom
Federal University of Rio Grande do Sul

Unknown

Non-damaging Retinal Laser Therapy With PASCAL Laser for Macular Diseases (EPM)

Diabetic Macular Edema | Branch Retinal Vein Occlusion | Macular Telangiectasia | Chronic Central Serous Retinopathy

Brazil
Terumo Europe N.V.

Completed

Post-Market Clinical Investigation of the FemoSeal™ VCS: A Prospective, Multi-Center Observational European Study (FEMOSEAL CLOSE)

Peripheral Vascular Disease | Hemostasis | Vascular Closure | Endovascular Procedure

Belgium, France, Germany
Alvotech Swiss AG

Active, not recruiting

Clinical Study to Evaluate the Handling and Safety of AVT06 PFS in Subjects With Chorioretinal Vascular Disease (ALVOEYE-D)

Chorioretinal Vascular Disease

Georgia
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Recruiting

Survey of Current Interventional and Diagnostic Imaging Residents After Participation in Endovascular Simulator Training

Malignant Vascular Neoplasm

United States
University of California, Irvine
University of Oklahoma; US Department of Veterans Affairs; C. R. Bard; Long Beach...

Completed

Femoral Arterial Access With Ultrasound Trial (FAUST)

Peripheral Vascular Disease | Cardiac Catheterization | Vascular Access Complications

United States
Amgen

Completed

A Study to Evaluate ABP 938 and Aflibercept (Eylea®) in Participants With Chorioretinal Vascular Disease (CVD)

Chorioretinal Vascular Disease

United States
Duke University

Terminated

Swept-Source Optical Coherence Tomography for Noninvasive Retinal Vascular Imaging (SWEPT)

Retinal Vascular Disease

United States
Regeneron Pharmaceuticals

Completed

Study to Evaluate an Aflibercept (EYLEA®) Prefilled Syringe

Chorioretinal Vascular Disease

United States
University Hospital, Montpellier

Terminated

Anti Vitamin K Therapeutic Education

Cardio-vascular Diseases

France
Allergan

Completed

A Long-Term Safety Study of OZURDEX® in Clinical Practice

Macular Edema | Retinal Vein Occlusion | Uveitis, Posterior

France, Spain, Germany, United Kingdom
I.M. Sechenov First Moscow State Medical University

Completed

The Effects of Intermittent Hypoxic-hyperoxic Preconditioning for Patients Undergoing Cardiopulmonary Bypass.

Surgery | Valvular Heart Disease | Aortic Arch Aneurysm

Russian Federation
University Hospital, Strasbourg, France

Unknown

Evaluation of the Brain Natriuretic Peptide as a Predictor of Morbidity and Mortality in Cardiac Surgery

Coronary Artery Disease | Valvular Disease

France
Université Catholique de Louvain

Completed

In Vivo Optical Spectroscopy Monitoring in a New Model of Muscular Compartment Syndrome

Human Volunteers

Belgium
Baylor University
National Institute on Aging (NIA)

Recruiting

The Role of microRNA-210 in Regulating Oxidative Stress in Patients With PAD

Arterial Occlusive Diseases | Peripheral Arterial Disease | Atherosclerosis | Vascular Diseases, Peripheral

United States
C. R. Bard
Cromsource

Completed

FLUENCY® PLUS in the Treatment of Peripheral Artery Disease

Vascular Diseases, Peripheral

Germany, Poland
Evasc Medical Systems Corp.
Radboud University Medical Center

Terminated

European eCLIPS™ Safety, Feasibility and Efficacy Study (EESIS)

Intracranial Aneurysm | Saccular Aneurysm

Netherlands, Denmark, Germany
Terumo Europe N.V.
Terumo Medical Corporation

Recruiting

Post-market Clinical Investigation of the Angio-Seal™ VIP VCD (ANGIO-SEAL CLOSE)

Peripheral Vascular Disease | Hemostasis | Vascular Closure | Femoral Artery | Endovascular Procedure

France, Germany, Netherlands
URAL Telekomunikasyon San. Trade Inc.

Completed

Detecting Eye Diseases Via Hybrid Deep Learning Algorithms From Fundus Images

Glaucoma | Eye Diseases | Age-Related Macular Degeneration | Diabetic Retinopathy | Diabetic Macular Edema | Retinal Vein Occlusion

Turkey
Alexandria University
Harvard Medical School (HMS and HSDM); Joslin Diabetes Center; I-care Ophthalmology...

Recruiting

Epidemiologic Assessment of Diabetic Retinopathy in Egypt Using Ultrawide Field Fundus Photographs

Diabetic Retinopathy | Diabetic Macular Edema | Retinal Disease

Egypt
PolyPhotonix Medical

Terminated

Noctura400 Treatment for Diabetic Retinopathy (CANDLE) (CANDLE)

Diabetic Macular Oedema

United Kingdom
Novartis Pharmaceuticals

Completed

Study to Show a Superior Benefit in Terms of Reduction of Ranibizumab Injections in Patients Receiving Ranibizumab Plus Laser Photocoagulation Combination Therapy Without Loss of Efficacy and Safety (ZIPANGU)

Macular Edema Secondary to Branch Retinal Vein Occlusion (BRVO)

Japan
Santen SAS

Completed

Safety and Tolerability of NOVA63035 "Corticosteroid" in Patients With Diabetic Macular Edema Secondary to Diabetic Retinopathy

Diabetic Macular Edema

United States
Novartis Pharmaceuticals

Completed

Ranibizumab Treatment of Diabetic Macular Oedema With Bimonthly Monitoring After a Phase of Initial Treatment (RELIGHT)

Diabetic Retinopathy | Macular Oedema

United Kingdom
Pfizer

Completed

Study To Evaluate Safety And Tolerability Of Pegaptanib Sodium In Patients With Diabetic Macular Edema

Diabetic Retinopathy | Diabetic Macular Edema | Anti- VGF Inhibitor

Spain, United Kingdom, Finland, Sweden
URAL Telekomunikasyon San. Trade Inc.
Akdeniz University

Recruiting

Assessment of EyeCheckup as an Automated Diabetic Retinopathy Screening Tool

Diabetic Retinopathy | Diabetic Macular Edema | Diabetic Eye Problems

Turkey
Adverum Biotechnologies, Inc.

Enrolling by invitation

Long-Term Follow-up Study of ADVM-022 in DME (INFINITY-EXT)

Diabetic Retinopathy | Diabetic Macular Edema

United States, Puerto Rico
Eyenuk, Inc.
National Eye Institute (NEI)

Completed

Assessment of EyeArt as an Automated Diabetic Retinopathy Screening Tool

Diabetic Retinopathy | Diabetic Macular Edema | Diabetic Eye Problems

United States
Jaeb Center for Health Research
National Eye Institute (NEI); Genentech, Inc.; Allergan

Completed

Laser-Ranibizumab-Triamcinolone for Proliferative Diabetic Retinopathy (LRTforDME+PRP)

Diabetic Macular Edema | Proliferative Diabetic Retinopathy

United States
Ursula Schmidt-Erfurth, M.D.

Completed

Bevacizumab Versus Ranibizumab for Diabetic Retinopathy

Diabetic Retinopathy | Diabetic Macular Edema | Proliferative Diabetic Retinopathy

Austria
Santen Inc.
MacuSight, Inc.

Completed

Safety and Tolerability of MS-R001 in Patients With Diabetic Macular Edema Secondary to Diabetic Retinopathy

Diabetic Retinopathy | Diabetic Macular Edema

United States
Unity Health Toronto

Unknown

Multi-spectral Imaging to Assess Wounds in Peripheral Vascular Disease Patients

Peripheral Vascular Disease Patient
University Hospital, Caen

Completed

Risk Factors for Portosinusoidal Vascular Disease in Kidney Transplant Recipients: (TRANSVAS)

Porto-Sinusoidal Vascular Disease

France
Rambam Health Care Campus

Unknown

Feasibility Study of Non-invasive and Continuous Measurement of Blood Pressure and Cardiac Output: Comparison to Non-invasive and Non-continuous Measurements

Heart or Vascular Disease

Israel

Clinical Trials on Vascular

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Ghana

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations